Sion M. Lewis

Bath Road
Slough, ENG SL13WE, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

A biomarker assay validation approach tailored to the context of use and bioanalytical platform.

A biomarker assay validation approach tailored to the context of use and bioanalytical platform.

Journal: Bioanalysis

Published: August 01, 2023

Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma.

Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 02, 2020

Early PREdiction of sepsis using leukocyte surface biomarkers: the ExPRES-sepsis cohort study.

Early PREdiction of sepsis using leukocyte surface biomarkers: the ExPRES-sepsis cohort study.

Journal: Intensive care medicine

Published: August 07, 2018

Cell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT study.

Cell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT study.

Journal: Intensive care medicine

Published: January 11, 2018

Early PREdiction of Severe Sepsis (ExPRES-Sepsis) study: protocol for an observational derivation study to discover potential leucocyte cell surface biomarkers.

Early PREdiction of Severe Sepsis (ExPRES-Sepsis) study: protocol for an observational derivation study to discover potential leucocyte cell surface biomarkers.

Journal: BMJ open

Published: August 03, 2016

Predictive value of cell-surface markers in infections in critically ill patients: protocol for an observational study (ImmuNe FailurE in Critical Therapy (INFECT) Study).

Predictive value of cell-surface markers in infections in critically ill patients: protocol for an observational study (ImmuNe FailurE in Critical Therapy (INFECT) Study).

Journal: BMJ open

Published: July 20, 2016

Targeting cytokines as a treatment for patients with sepsis: A lost cause or a strategy still worthy of pursuit?

Targeting cytokines as a treatment for patients with sepsis: A lost cause or a strategy still worthy of pursuit?

Journal: International immunopharmacology

Published: March 29, 2016

Expression of CD11c and EMR2 on neutrophils: potential diagnostic biomarkers for sepsis and systemic inflammation.

Expression of CD11c and EMR2 on neutrophils: potential diagnostic biomarkers for sepsis and systemic inflammation.

Journal: Clinical and experimental immunology

Published: May 28, 2015

The diagnostic and prognostic significance of monitoring blood levels of immature neutrophils in patients with systemic inflammation.

The diagnostic and prognostic significance of monitoring blood levels of immature neutrophils in patients with systemic inflammation.

Journal: Critical care (London, England)

Published: November 06, 2014

Depletion of blood neutrophils from patients with sepsis: treatment for the future?

Depletion of blood neutrophils from patients with sepsis: treatment for the future?

Journal: International immunopharmacology

Published: October 23, 2013

Neutrophils: the dawn of a new era? Preface.

Neutrophils: the dawn of a new era? Preface.

Journal: International immunopharmacology

Published: April 16, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026